Drug developer Generate Biomedicines raises $400 million in US IPO - Reuters

Reuters | Feb. 26, 2026, 8:11 p.m. | Original
Drug developer Generate Biomedicines raises $400 million in US IPO Reuters
Four Hong Kong listings seek $626 million as market revives after Lunar New Year - Reuters Denver mayor orders protection of protesters, ban on ICE from city property - TradingView